We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rising Generic Applications Lower Some User Fees for Fiscal 2017
Rising Generic Applications Lower Some User Fees for Fiscal 2017
An anticipated uptick in generic drug submissions is leading the FDA to lower its fees for approval applications and supplemental filings next fiscal year.